MRSN   $29.08  0.14% Market Closed

Mersana Therapeutics, Inc.
Total Cash 162.74M
totalCashPerShare 1.327
EBITDA -101.41M
Total Debt 32.93M
quickRatio 2.642
currentRatio 2.717
Total Revenue 29.94M
debtToEquity 390.803
Revenue/Share 0.247
ROA -0.26297
ROE -2.1333
grossProfits
freeCashflow -66.51M
operatingCashflow -132.56M
earningsGrowth
revenueGrowth -0.785
grossMargins -1.93807
ebitdaMargins 0.0
operatingMargins -11.10118
profitMargins 0.0
enterpriseValue 116.77M
forwardPE -3.3428571
floatShares 72.10M
sharesOutstanding 122.67M
sharesShort 9.97M
sharesShortPriorMonth 10.31M
dateShortInterest
sharesPercentSharesOut 0.08%
heldPercentInsiders 0.01%
heldPercentInstitutions 0.94%
Short Ratio help_outline 9.74%
shortPercentOfFloat 0.11%
impliedSharesOutstanding
bookValue 0.069
Price To Book help_outline 33.91
earningsQuarterlyGrowth
netIncomeToCommon -104.77M
trailingEps -0.85%
forwardEps -0.70%
enterpriseToEbitda -1.15
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.17 3Q 2024
institutionsCount 155
lastUpdated Nov. 7, 2024, 2:40 a.m.